Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans TU Krohne, N Eter, FG Holz, CH Meyer American journal of ophthalmology 146 (4), 508-512, 2008 | 450 | 2008 |
Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans TU Krohne, Z Liu, FG Holz, CH Meyer American journal of ophthalmology 154 (4), 682-686. e2, 2012 | 272 | 2012 |
Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration CK Chan, CH Meyer, JG Gross, P Abraham, ASD Nuthi, GT Kokame, ... Retina 27 (5), 541-551, 2007 | 207 | 2007 |
The use of vital dyes in ocular surgery EB Rodrigues, EF Costa, FM Penha, GB Melo, J Bottós, E Dib, B Furlani, ... Survey of ophthalmology 54 (5), 576-617, 2009 | 203 | 2009 |
Dynamic mechanical properties of human lenses HA Weeber, G Eckert, F Soergel, CH Meyer, W Pechhold, ... Experimental eye research 80 (3), 425-434, 2005 | 199 | 2005 |
Clinical use and research applications of Heidelberg retinal angiography and spectral‐domain optical coherence tomography–a review A Hassenstein, CH Meyer Clinical & experimental ophthalmology 37 (1), 130-143, 2009 | 156 | 2009 |
Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab. CH Meyer, FG Holz Eye 25 (6), 661-72., 2011 | 152 | 2011 |
Chromovitrectomy: a new field in vitreoretinal surgery EB Rodrigues, CH Meyer, P Kroll Graefe's Archive for Clinical and Experimental Ophthalmology 243, 291-293, 2005 | 151 | 2005 |
Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration CH Meyer, S Mennel, JC Schmidt, P Kroll British Journal of Ophthalmology 90 (9), 1207-1208, 2006 | 150 | 2006 |
Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high‐resolution, spectral‐domain optical coherence tomography HM Helb, PC Issa, M Fleckenstein, S Schmitz‐Valckenberg, HPN Scholl, ... Acta ophthalmologica 88 (8), 842-849, 2010 | 148 | 2010 |
Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus A Jain, S Saxena, VK Khanna, RK Shukla, CH Meyer Molecular Vision 19, 1760-8, 2013 | 140 | 2013 |
Intraocular pharmacokinetics after a single intravitreal injection of 1.5 mg versus 3.0 mg of bevacizumab in humans CH Meyer, TU Krohne, FG Holz Retina 31 (9), 1877-1884, 2011 | 138 | 2011 |
Optical coherence tomography–measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections CK Chan, P Abraham, CH Meyer, GT Kokame, PK Kaiser, ME Rauser, ... Retina 30 (2), 203-211, 2010 | 136 | 2010 |
Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study CH Meyer, HP Scholl, N Eter, HM Helb, FG Holz Acta ophthalmologica 86 (5), 490-494, 2008 | 132 | 2008 |
Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections CH Meyer, S Michels, EB Rodrigues, A Hager, S Mennel, JC Schmidt, ... Acta ophthalmologica 89 (1), 70-75, 2011 | 131 | 2011 |
Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration TD Ting, M Oh, TA Cox, CH Meyer, CA Toth Archives of Ophthalmology 120 (6), 731-737, 2002 | 128 | 2002 |
Vital dyes for chromovitrectomy EB Rodrigues, M Maia, CH Meyer, FM Penha, E Dib, ME Farah Current opinion in ophthalmology 18 (3), 179-187, 2007 | 127 | 2007 |
Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection EB Rodrigues, A Grumann Jr, FM Penha, H Shiroma, E Rossi, CH Meyer, ... Journal of Ocular Pharmacology and Therapeutics 27 (2), 197-203, 2011 | 122 | 2011 |
Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6‐month follow‐up–The SOLO study A Bezatis, G Spital, F Höhn, M Maier, CR Clemens, J Wachtlin, ... Acta ophthalmologica 91 (5), e340-e347, 2013 | 118 | 2013 |
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion GB Jaissle, P Szurman, N Feltgen, B Spitzer, A Pielen, M Rehak, G Spital, ... Graefe's Archive for Clinical and Experimental Ophthalmology 249, 183-192, 2011 | 113 | 2011 |